ABSTRACT
Nanoemulsions can be defined as oil-in-water or water-in-oil emulsions, which are prepared with the aid of surfactants and present droplets below a micron in size. In the pharmaceutical context, nanoemulsions are isotropic and kinetically stable dosage forms in which both hydrophobic and hydrophilic compounds can be effectively incorporated and explored for the treatment of different diseases. Most of the current pharmaceutical research in nanoemulsions has been directed for the treatment of inflammatory and
infectious diseases. Different formulations have been explored both as vehicles for drugs already available at the pharmaceutical market, and as adjuvants for the delivery of antigens to mucosal tissues. Here, we present recent advances on the pharmaceutical development of nanoemulsions for treating inflammatory and infectious diseases.
